Panagora Asset Management Inc. increased its holdings in HCA Healthcare Inc (NYSE:HCA) by 44.0% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 36,733 shares of the company’s stock after purchasing an additional 11,216 shares during the quarter. Panagora Asset Management Inc.’s holdings in HCA Healthcare were worth $5,110,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. Signet Financial Management LLC acquired a new stake in shares of HCA Healthcare during the second quarter valued at approximately $137,000. Bridgeworth LLC acquired a new stake in shares of HCA Healthcare during the second quarter valued at approximately $173,000. Smithfield Trust Co. raised its holdings in shares of HCA Healthcare by 41.2% during the third quarter. Smithfield Trust Co. now owns 1,405 shares of the company’s stock valued at $196,000 after acquiring an additional 410 shares during the period. Hyman Charles D acquired a new stake in shares of HCA Healthcare during the second quarter valued at approximately $205,000. Finally, Signition LP acquired a new stake in shares of HCA Healthcare during the second quarter valued at approximately $211,000. Institutional investors and hedge funds own 69.94% of the company’s stock.

HCA stock opened at $140.85 on Friday. The company has a market capitalization of $48.92 billion, a price-to-earnings ratio of 21.37, a price-to-earnings-growth ratio of 1.25 and a beta of 0.52. HCA Healthcare Inc has a 12 month low of $82.21 and a 12 month high of $147.42.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Tuesday, October 30th. The company reported $2.16 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.93 by $0.23. The company had revenue of $11.45 billion during the quarter, compared to the consensus estimate of $11.29 billion. HCA Healthcare had a net margin of 6.82% and a negative return on equity of 73.71%. The company’s revenue for the quarter was up 7.1% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.13 earnings per share. On average, sell-side analysts predict that HCA Healthcare Inc will post 9.34 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 28th. Shareholders of record on Monday, December 3rd will be given a $0.35 dividend. This represents a $1.40 annualized dividend and a yield of 0.99%. The ex-dividend date is Friday, November 30th. HCA Healthcare’s dividend payout ratio is 21.24%.

HCA has been the topic of a number of recent analyst reports. Zacks Investment Research upgraded shares of HCA Healthcare from a “hold” rating to a “buy” rating and set a $157.00 price target on the stock in a report on Monday, November 19th. Citigroup boosted their price target on shares of HCA Healthcare from $136.00 to $156.00 and gave the company a “buy” rating in a report on Thursday, October 11th. Royal Bank of Canada boosted their price target on shares of HCA Healthcare to $150.00 and gave the company an “outperform” rating in a report on Monday, September 10th. Bank of America boosted their price target on shares of HCA Healthcare from $125.00 to $135.00 and gave the company an “underperform” rating in a report on Tuesday, September 18th. Finally, UBS Group initiated coverage on shares of HCA Healthcare in a report on Thursday, November 15th. They set a “buy” rating and a $162.00 price target on the stock. Two analysts have rated the stock with a sell rating, five have given a hold rating and sixteen have issued a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average target price of $144.15.

In related news, SVP Deborah M. Reiner sold 723 shares of the company’s stock in a transaction on Monday, November 5th. The shares were sold at an average price of $135.06, for a total transaction of $97,648.38. Following the completion of the sale, the senior vice president now directly owns 6,184 shares of the company’s stock, valued at approximately $835,211.04. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, SVP Kathryn A. Torres sold 820 shares of the company’s stock in a transaction on Tuesday, November 13th. The stock was sold at an average price of $142.36, for a total transaction of $116,735.20. Following the sale, the senior vice president now directly owns 4,237 shares of the company’s stock, valued at $603,179.32. The disclosure for this sale can be found here. Insiders sold 16,763 shares of company stock valued at $2,346,147 over the last three months. Insiders own 2.80% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “Panagora Asset Management Inc. Grows Position in HCA Healthcare Inc (HCA)” was first posted by Watch List News and is owned by of Watch List News. If you are reading this story on another site, it was copied illegally and reposted in violation of U.S. & international trademark and copyright law. The original version of this story can be viewed at https://www.watchlistnews.com/panagora-asset-management-inc-grows-position-in-hca-healthcare-inc-hca/2668356.html.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Further Reading: Stop Order

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.